SLR Investment Corp.
For the period ended Jun 30, 2026. Filed Aug 4, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 4, 2026
What changed in Management’s Discussion and Analysis?
Read the current filingPrevious report: 10-Q
Period ended 2026-03-31; filed 2026-05-05.
0001193125-26-206311
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of OperationsCurrent report: 10-Q
Period ended 2026-06-30; filed 2026-08-04.
0001193125-26-332726
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of OperationsThe baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.
Compared 194 previous paragraphs and 198 current paragraphs.
156 unchanged; 27 reworded; 7 added; 3 removed; 8 previous and 8 current paragraphs rearranged.
Tables are not compared: 10 previous and 10 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.
A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.
Added paragraphs (7)
Current report
Credit had net income of $6.3 million and $8.7 million, respectively, on gross income of $21.0 million and $22.5 million,
Current report
June 30, 2026 and 2025, SLR Business Credit had net income of $4.2 million and $5.5 million, respectively, on gross income of $24.7
Current report
three and six months ended June 30, 2026, SSLP invested $6.7 million and $16.5 million, respectively, in 5 and 7 portfolio companies, respectively. Investments sold or prepaid totaled $11.8 million and $15.2 million, respectively for the three and six months ended June 30, 2026. For the three and six months ended June 30, 2025, SSLP invested $32.3 million and $38.8 million, respectively, in 7 and 9 portfolio companies, respectively. Investments sold or prepaid totaled $13.9 million and $33.8 million, respectively for the three and six months ended June 30, 2025.
Current report
Investment is on non-accrual status.
Current report
million, respectively.
Current report
For the three and six months ended June 30, 2026, gross investment income totaled $48.8 million and $98.1 million, respectively. For the three and six months ended June 30, 2025, gross investment income totaled $53.9 million and $107.1 million,
Current report
partially offset by depreciation in the value of our investments in SLR Equipment Finance, OmniGuide Holdings, Inc., SLR-AMI
Removed paragraphs (3)
Previous report
On April 15, 2026, revolving credit commitments to the Credit Facility were increased by $25 million with the addition of a new lender. Total revolving commitments now total $720 million.
Previous report
On May 4, 2026, the Board approved a Fourth Amended and Restated Investment Advisory and Management Agreement pursuant to which the performance-based incentive fee payable by the Company to our Investment Adviser was permanently reduced from 20% to 17.5%, beginning with the second quarter of 2026.
Previous report
Company’s outstanding shares of common stock. Under the repurchase program, the Company may, but is not obligated to,
Reworded paragraphs (27)
Previous wording
During the three months ended March 31, 2026, we invested approximately $118.7 million across 33 portfolio companies. This compares to investing approximately $193.5 million in 30 portfolio companies during the three months ended March 31, 2025. Investments sold, prepaid or repaid during the three months ended March 31, 2026 totaled approximately $137.5 million versus approximately $196.9 million for the three months ended March 31, 2025.
Current wording
During the three months ended June 30, 2026, we invested approximately $202.4 million across 28 portfolio companies. This compares to investing approximately $333.3 million in 33 portfolio companies during the three months ended June 30, 2025. Investments sold, prepaid or repaid during the three months ended June 30, 2026 totaled approximately $210.7 million versus approximately $209.4 million for the three months ended June 30, 2025.
Previous wording
At March 31, 2026, our portfolio consisted of 99 portfolio companies and was invested 22.5% in cash flow senior secured loans, 46.5% in asset-based senior secured loans / SLR Credit Solutions (“SLR Credit”) / SLR Healthcare ABL / SLR Business Credit, 20.8% in equipment senior secured financings / SLR Equipment Finance (“SLR Equipment”) / Kingsbridge Holdings, LLC (“KBH”) and 10.2% in life science investments, in each case, measured at fair value, versus 118 portfolio companies invested 28.6% in cash flow senior secured loans, 38.9% in asset-based senior secured loans / SLR Credit / SLR Healthcare ABL / SLR Business Credit, 21.6% in equipment senior secured financings / SLR Equipment / KBH, and 10.9% in life science investments, in each case, measured at fair value, at March 31, 2025.
Current wording
At June 30, 2026, our portfolio consisted of 79 portfolio companies and was invested 21.2% in cash flow senior secured loans, 47.9% in asset-based senior secured loans / SLR Credit Solutions (“SLR Credit”) / SLR Healthcare ABL / SLR Business Credit, 20.3% in equipment senior secured financings / SLR Equipment Finance (“SLR Equipment”) / Kingsbridge Holdings, LLC (“KBH”) and 10.6% in life science investments, in each case, measured at fair value, versus 115 portfolio companies invested 24.6% in cash flow senior secured loans, 44.8% in asset-based senior secured loans / SLR Credit / SLR Healthcare ABL / SLR Business Credit, 19.1% in equipment senior secured financings / SLR Equipment / KBH, and 11.5% in life science investments, in each case, measured at fair value, at June 30, 2025.
Previous wording
At March 31, 2026, 83.1%, or $1.72 billion, of our income producing investment portfolio* was floating rate and 16.9%, or $349.9 million, was fixed rate, measured at fair value. At March 31, 2025, 81.5%, or $1.61 billion, of our income producing investment portfolio* was floating rate and 18.5%, or $364.4 million, was fixed rate, measured at fair value. As of March 31, 2026 and 2025, we had zero and one issuer, respectively, on non-accrual status.
Current wording
At June 30, 2026, 83.2%, or $1.68 billion, of our income producing investment portfolio* was floating rate and 16.8%, or $339.4 million, was fixed rate, measured at fair value. At June 30, 2025, 82.9%, or $1.75 billion, of our income producing investment portfolio* was floating rate and 17.1%, or $359.8 million, was fixed rate, measured at fair value. As of June 30, 2026 and 2025, we had two and one issuers, respectively, on non-accrual status.
Previous wording
As of March 31, 2026, SLR Credit had 33 funded commitments to 26 different issuers with total funded loans of approximately $397.4 million on total assets of $412.3 million. As of December 31, 2025, SLR Credit had 33 funded commitments to 26 different issuers with total funded loans of approximately $404.1 million on total assets of $420.7 million. As of March 31, 2026 and December 31, 2025, the largest loan outstanding totaled $32.5 million and $29.9 million, respectively. For the same periods, the average exposure per issuer was $15.3 million and $15.5 million, respectively. SLR Credit’s credit facility, which is non-recourse to the Company, had approximately $212.7 million and $215.8 million of borrowings outstanding at March 31, 2026 and December 31, 2025, respectively. For the three months ended March 31, 2026 and 2025, SLR Credit had net income of $2.9 million and $5.2 million, respectively, on gross income of $10.0 million and $10.1 million, respectively. Due to timing and non-cash items, there may be material differences between U.S. generally accepted accounting principles (“GAAP”) net income and cash available for distributions. As such, and subject to fluctuations in SLR Credit’s funded commitments, the timing of originations, and the repayments of financings, the Company cannot guarantee that SLR Credit will be able to maintain consistent dividend payments to us.
Current wording
As of June 30, 2026, SLR Credit had 31 funded commitments to 23 different issuers with total funded loans of approximately $328.7 million on total assets of $349.8 million. As of December 31, 2025, SLR Credit had 33 funded commitments to 26 different issuers with total funded loans of approximately $404.1 million on total assets of $420.7 million. As of June 30, 2026 and December 31, 2025, the largest loan outstanding totaled $32.4 million and $29.9 million, respectively. For the same periods, the average exposure per issuer was $14.3 million and $15.5 million, respectively. SLR Credit’s credit facility, which is non-recourse to the Company, had approximately $150.0 million and $215.8 million of borrowings outstanding at June 30, 2026 and December 31, 2025, respectively. For the three months ended June 30, 2026 and 2025, SLR Credit had net income of $3.4 million and $3.5 million, respectively, on gross income of $11.0 million and $12.5 million, respectively. For the six months ended June 30, 2026 and 2025, SLR
Previous wording
As of March 31, 2026, SLR Equipment had 465 funded equipment-backed leases and loans to 236 different customers with a total net investment in leases and loans of approximately $290.9 million on total assets of $334.0 million. As of December 31, 2025, SLR Equipment had 485 funded equipment-backed leases and loans to 243 different customers with a total net investment in leases and loans of approximately $299.8 million on total assets of $338.3 million. As of March 31, 2026 and December 31, 2025, the largest position outstanding totaled $16.4 million and $17.8 million, respectively. For the same periods, the average exposure per customer was $1.2 million and $1.2 million, respectively. SLR Equipment’s credit facility, which is non-recourse to the Company, had approximately $232.3 million and $237.5 million of borrowings outstanding at March 31, 2026 and December 31, 2025, respectively. For the three months ended March 31, 2026 and 2025, SLR Equipment had net income (loss) of $3.7 million and ($1.9) million, respectively, on gross income of $10.1 million and $6.7 million, respectively. Due to timing and non-cash items, there may be material differences between GAAP net income and cash available for distributions. As such, and subject to fluctuations in SLR Equipment’s funded commitments, the timing of originations, and the repayments of financings, the Company cannot guarantee that SLR Equipment will be able to maintain consistent dividend payments to us.
Current wording
As of June 30, 2026, SLR Equipment had 497 funded equipment-backed leases and loans to 248 different customers with a total net investment in leases and loans of approximately $324.9 million on total assets of $361.7 million. As of December 31, 2025, SLR Equipment had 485 funded equipment-backed leases and loans to 243 different customers with a total net investment in leases and loans of approximately $299.8 million on total assets of $338.3 million. As of June 30, 2026 and December 31, 2025, the largest position outstanding totaled $18.7 million and $17.8 million, respectively. For the same periods, the average exposure per customer was $1.3 million and $1.2 million, respectively. SLR Equipment’s credit facility, which is non-recourse to the Company, had approximately $244.2 million and $237.5 million of borrowings outstanding at June 30, 2026 and December 31, 2025, respectively. For the three months ended June 30, 2026 and 2025, SLR Equipment had net income of $4.3 million and $2.6 million, respectively, on gross income of $11.2 million and $8.8 million, respectively. For the six months ended June 30, 2026 and 2025, SLR Equipment had net income of $8.0 million and $0.6 million, respectively, on gross income of $21.3 million and $15.4 million, respectively. Due to timing and non-cash items, there may be material differences between GAAP net income and cash available for distributions. As such, and subject to fluctuations in SLR Equipment’s funded commitments, the timing of originations, and the repayments of financings, the Company cannot guarantee that SLR Equipment will be able to maintain consistent dividend payments to us.
Previous wording
On November 3, 2020, the Company acquired 87.5% of the equity securities of Kingsbridge Holdings, LLC through KBH Topco LLC (“KBHT”), a Delaware corporation. KBH is a residual focused independent mid-ticket lessor of equipment primarily to U.S. investment grade companies. The Company invested $216.6 million to effect the transaction, of which $136.6 million was invested to acquire 87.5% of KBHT’s equity and $80.0 million of KBH’s debt. The existing management team of KBH committed to continuing to lead KBH after the transaction. Following the transaction, the Company owns 87.5% of KBHT’s equity and the KBH management team owns the remaining 12.5% of KBHT’s equity. On March 13, 2024, as per the terms of the original purchase agreement, the Company acquired 3.125% of KBHT’s equity from the KBH management team. On March 11, 2025, as per the terms of the original purchase agreement, the Company acquired an additional 3.125% of KBHT’s equity from the KBH management team.
Current wording
On November 3, 2020, the Company acquired 87.5% of the equity securities of Kingsbridge Holdings, LLC through KBH Topco LLC (“KBHT”), a Delaware corporation. KBH is a residual focused independent mid-ticket lessor of equipment primarily to U.S. investment grade companies. The Company invested $216.6 million to effect the transaction, of which $136.6 million was invested to acquire 87.5% of KBHT’s equity and $80.0 million of KBH’s debt. The existing management team of KBH committed to continuing to lead KBH after the transaction. Following the transaction, the Company owns 87.5% of KBHT’s equity and the KBH management team owns the remaining 12.5% of KBHT’s equity. On March 13, 2024, as per the terms of the original purchase agreement, the Company acquired 3.125% of KBHT’s equity from the KBH management team. On March 11, 2025, as per the terms of the original purchase agreement, the Company acquired an additional 3.125% of KBHT’s equity from the KBH management team. On March 16, 2026, as per the terms of the original purchase agreement, the Company acquired an additional 6.25% of KBHT’s equity from the KBH management team. Effective with these purchases, the Company owns 100% of KBHT’s equity.
Previous wording
As of March 31, 2026 and December 31, 2025, KBHT had total assets of $956.4 million and $940.3 million, respectively. For the same periods, debt recourse to KBHT totaled $320.0 million and $309.4 million, respectively, and non-recourse debt totaled $406.0 million and $407.8 million, respectively. None of the debt is recourse to the Company. For the three months ended March 31, 2026 and 2025, KBHT had net income of $1.4 million and $3.4 million, respectively, on gross income of $70.8 million and $97.9 million, respectively. Due to timing and non-cash items, there may be material differences between GAAP net income and cash available for distributions. As such, and subject to fluctuations in KBHT’s funded commitments, the timing of originations, and the repayments of financings, the Company cannot guarantee that KBHT will be able to maintain consistent dividend payments to us.
Current wording
As of June 30, 2026 and December 31, 2025, KBHT had total assets of $971.0 million and $940.3 million, respectively. For the same periods, debt recourse to KBHT totaled $312.2 million and $309.4 million, respectively, and non-recourse debt totaled $400.3 million and $407.8 million, respectively. None of the debt is recourse to the Company. For the three months ended June 30, 2026 and 2025, KBHT had net income (loss) of $(0.1) million and $2.9 million, respectively, on gross income of $177.5 million and $90.0 million, respectively. For the six months ended June 30, 2026 and 2025, KBHT had net income of $1.4 million and $6.2 million, respectively, on gross income of $248.3 million and $187.9 million, respectively. Due to timing and non-cash items, there may be material differences between GAAP net income and cash available for distributions. As such, and subject to fluctuations in KBHT’s funded commitments, the timing of originations, and the repayments of financings, the Company cannot guarantee that KBHT will be able to maintain consistent dividend payments to us.
Previous wording
SLR Healthcare currently manages a highly diverse portfolio of directly-originated and underwritten senior-secured commitments. As of March 31, 2026, the portfolio totaled approximately $253.3 million of commitments with a total net investment in loans of $111.1 million on total assets of $119.6 million. As of December 31, 2025, the portfolio totaled approximately $297.8 million of commitments with a total net investment in loans of $157.0 million on total assets of $165.4 million. At March 31, 2026, the portfolio consisted of 48 issuers with an average balance of approximately $2.3 million versus 48 issuers with an average balance of approximately $3.3 million at December 31, 2025. All of the commitments in SLR Healthcare’s portfolio are floating-rate, senior-secured, cash-pay loans. SLR Healthcare’s credit facility, which is non-recourse to us, had approximately $83.9 million and $127.2 million of borrowings outstanding at March 31, 2026 and December 31, 2025, respectively. For the three months ended March 31, 2026 and 2025, SLR Healthcare had net income of $1.8 million and $1.4 million, respectively, on gross income of $5.6 million and $5.3 million, respectively. Due to timing and non-cash items, there may be material differences between GAAP net income and cash available for distributions. As such, and subject to fluctuations in SLR Healthcare’s funded commitments, the timing of originations, and the repayment of financings, the Company cannot guarantee that SLR Healthcare will be able to maintain consistent dividend payments to us.
Current wording
SLR Healthcare currently manages a highly diverse portfolio of directly-originated and underwritten senior-secured commitments. As of June 30, 2026, the portfolio totaled approximately $259.3 million of commitments with a total net investment in loans of $123.7 million on total assets of $133.4 million. As of December 31, 2025, the portfolio totaled approximately $297.8 million of commitments with a total net investment in loans of $157.0 million on total assets of $165.4 million. At June 30, 2026, the portfolio consisted of 48 issuers with an average balance of approximately $2.6 million versus 48 issuers with an average balance of approximately $3.3 million at December 31, 2025. All of the commitments in SLR Healthcare’s portfolio are floating-rate, senior-secured, cash-pay loans. SLR Healthcare’s credit facility, which is non-recourse to us, had approximately $95.7 million and $127.2 million of borrowings outstanding at June 30, 2026 and December 31, 2025, respectively. For the three months ended June 30, 2026 and 2025, SLR Healthcare had net income of $1.3 million and $1.5 million, respectively, on gross income of $4.6 million and $5.8 million, respectively. For the six months ended June 30, 2026 and 2025, SLR Healthcare had net income of $3.1 million and $2.9
Previous wording
SLR Business Credit currently manages a highly diverse portfolio of directly-originated and underwritten senior-secured commitments. As of March 31, 2026, the portfolio totaled approximately $909.1 million of commitments, of which, on a net basis, approximately $524.1 million were funded, on total assets of $568.6 million. As of December 31, 2025, the portfolio totaled approximately $920.4 million of commitments, of which $535.2 million were funded, on total assets of $574.1 million. At March 31, 2026, the portfolio consisted of 178 issuers with an average balance of approximately $2.9 million versus 179 issuers with an average balance of approximately $3.0 million at December 31, 2025. NMC has a senior credit facility with a bank lending group for $367.0 million, which expires on November 13, 2028. Borrowings are secured by substantially all of NMC’s assets. NMC’s credit facility, which is non-recourse to us, had approximately $254.2 million and $273.2 million of borrowings outstanding at March 31, 2026 and December 31, 2025, respectively. For the three months ended March 31, 2026 and 2025, SLR Business Credit had net income of $1.9 million and $2.6 million, respectively, on gross income of $12.0 million and $12.9 million, respectively. Due to timing and non-cash items, there may be material differences between GAAP net income and cash available for distributions. As such, and subject to fluctuations in SLR Business Credit’s funded commitments, the timing of originations, and the repayments of financings, the Company cannot guarantee that SLR Business Credit will be able to maintain consistent dividend payments to us.
Current wording
SLR Business Credit currently manages a highly diverse portfolio of directly-originated and underwritten senior-secured commitments. As of June 30, 2026, the portfolio totaled approximately $925.8 million of commitments, of which, on a net basis, approximately $597.6 million were funded, on total assets of $642.9 million. As of December 31, 2025, the portfolio totaled approximately $920.4 million of commitments, of which $535.2 million were funded, on total assets of $574.1 million. At June 30, 2026, the portfolio consisted of 168 issuers with an average balance of approximately $3.6 million versus 179 issuers with an average balance of approximately $3.0 million at December 31, 2025. NMC has a senior credit facility with a bank lending group for $367.0 million, which expires on November 13, 2028. Borrowings are secured by substantially all of NMC’s assets. NMC’s credit facility, which is non-recourse to us, had approximately $325.6 million and $273.2 million of borrowings outstanding at June 30, 2026 and December 31, 2025, respectively. For the three months ended June 30, 2026 and 2025, SLR Business Credit had net income of $2.3 million and $2.9 million, respectively, on gross income of $12.7 million and $13.2 million, respectively. For the six months ended
Previous wording
a rate of SOFR plus 2.15% (the “SSLP Facility”). SSLP and SSLP SPV, as applicable, have made certain customary representations and warranties and are required to comply with various covenants, including leverage restrictions, reporting requirements and other customary requirements for similar credit facilities. The SSLP Facility also includes usual and customary events of default for credit facilities of this nature. At March 31, 2026 and December 31, 2025, borrowings outstanding on the SSLP Facility totaled $96.5 million and $94.5 million, respectively.
Current wording
a rate of SOFR plus 2.15% (the “SSLP Facility”). SSLP and SSLP SPV, as applicable, have made certain customary representations and warranties and are required to comply with various covenants, including leverage restrictions, reporting requirements and other customary requirements for similar credit facilities. The SSLP Facility also includes usual and customary events of default for credit facilities of this nature. At June 30, 2026 and December 31, 2025, borrowings outstanding on the SSLP Facility totaled $94.1 million and $94.5 million, respectively.
Previous wording
As of March 31, 2026 and December 31, 2025, SSLP had total assets of $194.9 million and $192.8 million, respectively. For the same periods, SSLP’s portfolio consisted of floating rate senior secured loans to 25 and 25 different borrowers, respectively. For the three months ended March 31, 2026, SSLP invested $9.8 million in 5 portfolio companies. Investments sold or prepaid totaled $3.4 million for the three months ended March 31, 2026. For the three months ended March 31, 2025, SSLP invested $6.6 million in 6 portfolio companies. Investments prepaid totaled $19.9 million for the three months ended March 31, 2025.
Current wording
As of June 30, 2026 and December 31, 2025, SSLP had total assets of $191.0 million and $192.8 million, respectively. For the same periods, SSLP’s portfolio consisted of floating rate senior secured loans to 25 and 25 different borrowers, respectively. For the
Previous wording
Below is certain summarized financial information for SSLP as of March 31, 2026 and December 31, 2025 and for the three and three months ended March 31, 2026 and 2024:
Current wording
Below is certain summarized financial information for SSLP as of June 30, 2026 and December 31, 2025 and for the three and six months ended June 30, 2026 and 2025:
Previous wording
The typically higher yields and interest rates on PIK securities, to the extent we invested, reflect the payment deferral and increased credit risks associated with such instruments and that such investments may represent a significantly higher credit risk than coupon loans. PIK securities may have unreliable valuations because their continuing accruals require continuing judgments about the collectability of the deferred payments and the value of any associated collateral. PIK income has the effect of generating investment income and increasing the incentive fees payable at a compounding rate. In addition, the deferral of PIK income also increases the loan-to-value ratio at a compounding rate. PIK securities create the risk that incentive fees will be paid to the Investment Adviser based on non-cash accruals that ultimately may not be realized, but the Investment Adviser will be under no obligation to reimburse the Company for these fees. For the three months ended March 31, 2026 and 2025, capitalized PIK income totaled $5.6 million and $1.7 million, respectively.
Current wording
The typically higher yields and interest rates on PIK securities, to the extent we invested, reflect the payment deferral and increased credit risks associated with such instruments and that such investments may represent a significantly higher credit risk than coupon loans. PIK securities may have unreliable valuations because their continuing accruals require continuing judgments about the collectability of the deferred payments and the value of any associated collateral. PIK income has the effect of generating investment income and increasing the incentive fees payable at a compounding rate. In addition, the deferral of PIK income also increases the loan-to-value ratio at a compounding rate. PIK securities create the risk that incentive fees will be paid to the Investment Adviser based on non-cash accruals that ultimately may not be realized, but the Investment Adviser will be under no obligation to reimburse the Company for these fees. For the three and six months ended June 30, 2026, capitalized PIK income totaled $1.7 million and $7.4 million, respectively. For the three and six months ended June 30, 2025, capitalized PIK income totaled $1.8 million and $3.5
Previous wording
Results comparisons for the three months ended March 31, 2026 and March 31, 2025 are presented below:
Current wording
Results comparisons for the three and six months ended June 30, 2026 and June 30, 2025 are presented below:
Previous wording
For the three months ended March 31, 2026 and 2025, gross investment income totaled $49.3 million and $53.2 million, respectively. The decrease in gross investment income for the year over year three month periods was primarily due to a decrease in index rates.
Current wording
respectively. The decrease in gross investment income for the year over year three month periods was primarily due to a decrease in size of the income-producing portfolio.
Previous wording
Net expenses totaled $31.4 million and $31.1 million, respectively, for the three months ended March 31, 2026 and 2025, of which $12.2 million and $13.0 million, respectively, consisted of base management fees and performance-based incentive fees and $16.4 million and $15.8 million, respectively, consisted of interest and other credit facility expenses. Other general and administrative expenses totaled $2.8 million and $2.2 million, respectively, for the three months ended March 31, 2026 and 2025. Over the same periods, $14 thousand and $2 thousand of performance-based incentive fees were waived. Expenses generally consist of management and performance-based incentive fees, interest and other credit facility expenses, administrative services fees, insurance expenses, legal fees, directors’ fees, transfer agency fees, printing and proxy expenses, audit and tax services expenses and other general and administrative expenses. Interest and other credit facility expenses generally consist of interest, unused fees, agency fees and loan origination fees, if any, among others. The increase in expenses for the year over year three month periods was primarily due to higher interest expense from an increase in average borrowings.
Current wording
Net expenses totaled $31.1 million and $62.5 million, respectively, for the three and six months ended June 30, 2026, of which $11.6 million and $23.9 million, respectively, consisted of base management fees and performance-based incentive fees and $16.8 million and $33.2 million, respectively, consisted of interest and other credit facility expenses. Other general and administrative expenses totaled $2.7 million and $5.5 million, respectively, for the three and six months ended June 30, 2026. Over the same periods, $16 thousand and $30 thousand of performance-based incentive fees were waived. Net expenses totaled $32.3 million and $63.4 million, respectively, for the three and six months ended June 30, 2025, of which $13.2 million and $26.2 million, respectively, consisted of base management fees and performance-based incentive fees and $16.7 million and $32.6 million, respectively, consisted of interest and other credit facility expenses. Other general and administrative expenses totaled $2.4 million and $4.6 million, respectively, for the three and six months ended June 30, 2025. Over the same periods, $20 thousand and $22 thousand of performance-based incentive fees were waived. Expenses generally consist of management and performance-based incentive fees, interest and other credit facility expenses, administrative services fees, insurance expenses, legal fees, directors’ fees, transfer agency fees, printing and proxy expenses, audit and tax services expenses and other general and administrative expenses. Interest and other credit facility expenses generally consist of interest, unused fees, agency fees and loan origination fees, if any, among others. The decrease in expenses for the year over year three month and six month periods was primarily due to lower incentive fees on lower net investment income.
Previous wording
The Company’s net investment income totaled $17.9 million and $22.1 million, or $0.33 and $0.41, per average share, respectively, for the three months ended March 31, 2026 and 2025.
Current wording
The Company’s net investment income totaled $17.8 million and $35.6 million, or $0.33 and $0.65, per average share, respectively, for the three and six months ended June 30, 2026. The Company’s net investment income totaled $21.6 million and $43.7 million, or $0.40 and $0.80, per average share, respectively, for the three and six months ended June 30, 2025.
Previous wording
The Company had investment sales and prepayments totaling approximately $138 million and $197 million, respectively, for the three months ended March 31, 2026 and 2025. Net realized losses over the same periods were $27 thousand and $422 thousand, respectively. Net realized loss for the three months ended March 31, 2026 and 2025 were primarily due to the disposition of selected assets.
Current wording
The Company had investment sales and prepayments totaling approximately $211 million and $348 million, respectively, for the three and six months ended June 30, 2026. Net realized losses over the same periods were $152 thousand and $179 thousand, respectively. The Company had investment sales and prepayments totaling approximately $209 million and $406 million, respectively, for the three and six months ended June 30, 2025. Net realized gain (loss) over the same periods were $0.2 million and $(0.2) million,
Previous wording
For the three months ended March 31, 2026 and 2025, net change in unrealized gain (loss) on the Company’s assets totaled ($0.7) million and ($1.8) million, respectively. Net unrealized loss for the three months ended March 31, 2026 was primarily due to depreciation in the value of our investments in Omniguide Holdings, Inc. and RQM+ Corp., among others, partially offset by appreciation in the value of our investments in KBH Topco, LLC, SLR Business Credit and SLR Equipment Finance, among others. Net unrealized loss for the three months ended March 31, 2025 was primarily due to depreciation in the value of our investments in SLR Equipment Finance, SLR-AMI Topco Blocker, LLC and SLR Senior Lending Program LLC, among others, as well as the reversal of previously recognized unrealized appreciation upon the exit of our investments in Outset Medical, Inc. and Retina Midco, Inc., partially offset by appreciation in the value of our investments in KBH Topco, LLC, SLR Business Credit and Bayside Parent, LLC, among others
Current wording
For the three and six months ended June 30, 2026, net change in unrealized gain (loss) on the Company’s assets totaled ($9.3) million and ($10.0) million, respectively. Net unrealized loss for the three months ended June 30, 2026 was primarily due to depreciation in the value of our investments in Omniguide Holdings, Inc., iCIMS, Inc., RQM+ Corp. and SLR-AMI Topco Blocker LLC, among others, partially offset by appreciation in the value of our investments in Enhanced Permanent Capital, LLC, SLR Business Credit and SLR Equipment Finance, among others. Net unrealized loss for the six months ended June 30, 2026 was primarily due to depreciation in the value of our investments in Omniguide Holdings, Inc., RQM+ Corp., iCIMS, Inc., SLR-AMI Topco Blocker LLC and SLR Senior Lending Program LLC, among others, partially offset by appreciation in the value of our investments in SLR Business Credit, KBH Topco LLC, SLR Equipment Finance and Enhanced Permanent Capital, LLC, among others. For the three and six months ended June 30, 2025, net change in unrealized gain on the Company’s assets totaled $2.4 million and $0.6 million, respectively. Net unrealized gain for the three months ended June 30, 2025 was primarily due to appreciation in the value of our investments in KBH Topco, LLC, DeepIntent, Inc., SLR Business Credit and Bayside Parent, LLC, among others,
Previous wording
For the three months ended March 31, 2026 and 2025, the Company had a net increase in net assets resulting from operations of $17.1 million and $19.9 million, respectively. For the same periods, earnings per average share were $0.31 and $0.37, respectively.
Current wording
For the three and six months ended June 30, 2026, the Company had a net increase in net assets resulting from operations of $8.3 million and $25.4 million, respectively. For the same periods, earnings per average share were $0.15 and $0.47, respectively. For the three and six months ended June 30, 2025, the Company had a net increase in net assets resulting from operations of $24.2 million and $44.2 million, respectively. For the same periods, earnings per average share were $0.44 and $0.81, respectively.
Previous wording
The Company’s liquidity and capital resources are generated and generally available through its Credit Facility and SPV Credit Facility (as defined below), the 2026 Unsecured Notes, the 2027 Unsecured Notes, the 2027 Series F Unsecured Notes, the 2027 Series G Unsecured Notes, the 2028 Series H Unsecured Notes, the 2028 Series I Unsecured Notes and the 2028 Series J Unsecured Notes (collectively the “Debt Instruments”), through cash flows from operations, investment sales, prepayments of senior and subordinated loans, income earned on investments and cash equivalents, and periodic follow-on equity and/or debt offerings. As of March 31, 2026, we had a total of $458.4 million of collective unused borrowing capacity under the Credit Facility and SPV Credit Facility, subject to borrowing base limits.
Current wording
The Company’s liquidity and capital resources are generated and generally available through its Credit Facility and SPV Credit Facility (as defined below), the 2026 Unsecured Notes, the 2027 Unsecured Notes, the 2027 Series F Unsecured Notes, the 2027 Series G Unsecured Notes, the 2028 Series H Unsecured Notes, the 2028 Series I Unsecured Notes and the 2028 Series J Unsecured Notes (collectively the “Debt Instruments”), through cash flows from operations, investment sales, prepayments of senior and subordinated loans, income earned on investments and cash equivalents, and periodic follow-on equity and/or debt offerings. As of June 30, 2026, we had a total of $465.4 million of collective unused borrowing capacity under the Credit Facility and SPV Credit Facility, subject to borrowing base limits.
Previous wording
For the three months ended March 31, 2026 and 2025, the Company sold no shares of common stock under the Equity Distribution Agreement. As of March 31, 2026, shares representing $150.0 million of our common stock remain available for issuance and sale under the Equity Distribution Agreement.
Current wording
For the three and six months ended June 30, 2026 and 2025, the Company sold no shares of common stock under the Equity Distribution Agreement. As of June 30, 2026, shares representing $150.0 million of our common stock remain available for issuance and sale under the Equity Distribution Agreement.
Previous wording
On August 16, 2024, the Company closed on Amendment No. 3 to its August 28, 2019 senior secured credit agreement (as amended to date, the “Credit Facility”). Following this amendment and several commitment increases between the fourth quarter of 2024 and the third quarter of 2025 and a commitment decrease in the fourth quarter of 2025 related to a lender who did not extend their commitment with Amendment No. 3, the Credit Facility is now composed of $695.0 million of revolving credit and $153.1 million of term loans. Borrowings generally bear interest at a rate per annum equal to the base rate plus a range of 1.75%-2.00% or the alternate base rate plus 0.75%-1.00%. The Credit Facility has a 0% floor, matures in August 2029 and includes ratable amortization in the final year. Subsequent to Amendment No. 4 on December 3, 2024, the Credit Facility may be increased up to $900 million with additional new lenders or an increase in commitments from current lenders. The Credit Facility contains certain customary affirmative and negative covenants and events of default. In addition, the Credit Facility contains certain financial covenants that, among other things, require the Company to maintain a minimum stockholder’s equity and a minimum asset coverage ratio. At March 31, 2026, outstanding USD equivalent borrowings under the Credit Facility totaled $496.4 million, composed of $346.5 million of revolving credit and $149.9 million of term loans.
Current wording
On August 16, 2024, the Company closed on Amendment No. 3 to its August 28, 2019 senior secured credit agreement (as amended to date, the “Credit Facility”). Following this amendment and several commitment increases between the fourth quarter of 2024 and the second quarter of 2026 and a commitment decrease in the fourth quarter of 2025 related to a lender who did not extend their commitment with Amendment No. 3, the Credit Facility is now composed of $720.0 million of revolving credit and $146.6 million of term loans. Borrowings generally bear interest at a rate per annum equal to the base rate plus a range of 1.75%-2.00% or the alternate base rate plus 0.75%-1.00%. The Credit Facility has a 0% floor, matures in August 2029 and includes ratable amortization in the final year. Subsequent to Amendment No. 4 on December 3, 2024, the Credit Facility may be increased up to $900 million with additional new lenders or an increase in commitments from current lenders. The Credit Facility contains certain customary affirmative and negative covenants and events of default. In addition, the Credit Facility contains certain financial covenants that, among other things, require the Company to maintain a minimum stockholder’s equity and a minimum asset coverage ratio. At June 30, 2026, outstanding USD equivalent borrowings under the Credit Facility totaled $552.1 million, composed of $405.5 million of revolving credit and $146.6 million of term loans.
Previous wording
On April 1, 2022, we entered into an assumption agreement (the “CF Assumption Agreement”), effective as of the closing of the SUNS acquisition. The CF Assumption Agreement relates to our assumption of the revolving credit facility, originally entered into on August 26, 2011 (as amended from time to time, the “SPV Credit Facility”), by and among SUNS SPV LLC (the “SUNS SPV”), a wholly-owned subsidiary of SUNS, acting as borrower, Citibank, N.A., acting as administrative agent and collateral agent, and the other parties thereto. Currently, subsequent to an August 30, 2024 amendment, the commitment under the SPV Credit Facility is $275 million. The stated interest rate on the SPV Credit Facility is SOFR plus 2.25%-2.75% with no SOFR floor requirement, and the current final maturity date is August 30, 2028. The SPV Credit Facility is secured by all of the assets held by SUNS SPV. Under the terms of the SPV Credit Facility and related transaction documents, we, as successor to SUNS, and SUNS SPV, as applicable, have made certain customary representations and warranties and are required to comply with various covenants, including leverage restrictions, reporting requirements and other customary requirements for similar credit facilities. The SPV Credit Facility also includes usual and customary events of default for credit facilities of this nature. At March 31, 2026, outstanding USD equivalent borrowings under the SPV Credit Facility totaled $165.1 million.
Current wording
On April 1, 2022, we entered into an assumption agreement (the “CF Assumption Agreement”), effective as of the closing of the SUNS acquisition. The CF Assumption Agreement relates to our assumption of the revolving credit facility, originally entered into on August 26, 2011 (as amended from time to time, the “SPV Credit Facility”), by and among SUNS SPV LLC (the “SUNS SPV”), a wholly-owned subsidiary of SUNS, acting as borrower, Citibank, N.A., acting as administrative agent and collateral agent, and the other parties thereto. Currently, subsequent to an August 30, 2024 amendment, the commitment under the SPV Credit Facility is $275 million. The stated interest rate on the SPV Credit Facility is SOFR plus 2.25%-2.75% with no SOFR floor requirement, and the current final maturity date is August 30, 2028. The SPV Credit Facility is secured by all of the assets held by SUNS SPV. Under the terms of the SPV Credit Facility and related transaction documents, we, as successor to SUNS, and SUNS SPV, as applicable, have made certain customary representations and warranties and are required to comply with various covenants, including leverage restrictions, reporting requirements and other customary requirements for similar credit facilities. The SPV Credit Facility also includes usual and customary events of default for credit facilities of this nature. At June 30, 2026, outstanding USD equivalent borrowings under the SPV Credit Facility totaled $124.1 million.
Previous wording
We deem certain U.S. Treasury bills, repurchase agreements and other high-quality, short-term debt securities as cash equivalents. The Company makes purchases that are consistent with its purpose of making investments in securities described in paragraphs 1 through 3 of Section 55(a) of the 1940 Act. From time to time, including at or near the end of each fiscal quarter, we consider using various temporary investment strategies for our business. One strategy includes taking proactive steps by utilizing cash equivalents as temporary assets with the objective of enhancing our investment flexibility pursuant to Section 55 of the 1940 Act. More specifically, from time to time we may purchase U.S. Treasury bills or other high-quality, short-term debt securities at or near the end of the quarter and typically close out the position on a net cash basis subsequent to quarter end. We may also utilize repurchase agreements or other balance sheet transactions, including drawing down on the Credit Facility, as deemed appropriate. The amount of these transactions or such drawn cash for this purpose are excluded from total assets for purposes of computing the asset base upon which the management fee is determined. As of March 31, 2026 and December 31, 2025, we held face amounts of $390 million and $350 million, respectively, in cash equivalents.
Current wording
We deem certain U.S. Treasury bills, repurchase agreements and other high-quality, short-term debt securities as cash equivalents. The Company makes purchases that are consistent with its purpose of making investments in securities described in paragraphs 1 through 3 of Section 55(a) of the 1940 Act. From time to time, including at or near the end of each fiscal quarter, we consider using various temporary investment strategies for our business. One strategy includes taking proactive steps by utilizing cash equivalents as temporary assets with the objective of enhancing our investment flexibility pursuant to Section 55 of the 1940 Act. More specifically, from time to time we may purchase U.S. Treasury bills or other high-quality, short-term debt securities at or near the end of the quarter and typically close out the position on a net cash basis subsequent to quarter end. We may also utilize repurchase agreements or other balance sheet transactions, including drawing down on the Credit Facility, as deemed appropriate. The amount of these transactions or such drawn cash for this purpose are excluded from total assets for purposes of computing the asset base upon which the management fee is determined. As of June 30, 2026 and December 31, 2025, we held face amounts of $400 million and $350 million, respectively, in cash equivalents.
Previous wording
As of March 31, 2026, we had a total of $458.4 million of unused borrowing capacity under our revolving credit facilities, subject to borrowing base limits.
Current wording
As of June 30, 2026, we had a total of $465.4 million of unused borrowing capacity under our revolving credit facilities, subject to borrowing base limits.
Previous wording
The asset coverage ratio for a class of senior securities representing indebtedness is calculated as our consolidated total assets, less all liabilities and indebtedness not represented by senior securities, divided by all senior securities representing indebtedness. This asset coverage ratio is multiplied by one thousand to determine the Asset Coverage Per Unit. In order to determine the specific Asset Coverage Per Unit for each class of debt, the total Asset Coverage Per Unit is allocated based on the amount outstanding in each class of debt at the end of the period. As of March 31, 2026, asset coverage was 186.5%.
Current wording
The asset coverage ratio for a class of senior securities representing indebtedness is calculated as our consolidated total assets, less all liabilities and indebtedness not represented by senior securities, divided by all senior securities representing indebtedness. This asset coverage ratio is multiplied by one thousand to determine the Asset Coverage Per Unit. In order to determine the specific Asset Coverage Per Unit for each class of debt, the total Asset Coverage Per Unit is allocated based on the amount outstanding in each class of debt at the end of the period. As of June 30, 2026, asset coverage was 184.7%.
Rearranged current paragraphs (8)
Current report — wording carried from elsewhere
respectively. Due to timing and non-cash items, there may be material differences between U.S. generally accepted accounting principles (“GAAP”) net income and cash available for distributions. As such, and subject to fluctuations in SLR Credit’s funded commitments, the timing of originations, and the repayments of financings, the Company cannot guarantee that SLR Credit will be able to maintain consistent dividend payments to us.
Current report — wording carried from elsewhere
million, respectively, on gross income of $10.1 million and $11.1 million, respectively. Due to timing and non-cash items, there may be material differences between GAAP net income and cash available for distributions. As such, and subject to fluctuations in SLR Healthcare’s funded commitments, the timing of originations, and the repayment of financings, the Company cannot guarantee that SLR Healthcare will be able to maintain consistent dividend payments to us.
Current report — wording carried from elsewhere
million and $26.2 million, respectively. Due to timing and non-cash items, there may be material differences between GAAP net income and cash available for distributions. As such, and subject to fluctuations in SLR Business Credit’s funded commitments, the timing of originations, and the repayments of financings, the Company cannot guarantee that SLR Business Credit will be able to maintain consistent dividend payments to us.
Current report — wording carried from elsewhere
respectively. Net realized loss for the three and six months ended June 30, 2026 and 2025 were primarily due to the disposition of selected assets.
Current report — wording carried from elsewhere
Topco Blocker, LLC and RQM+ Corp., among others. Net unrealized gain for the six months ended June 30, 2025 was primarily due to appreciation in the value of our investments in KBH Topco, LLC, SLR Business Credit, DeepIntent, Inc. and Bayside Parent, LLC,
Current report — wording carried from elsewhere
among others, partially offset by depreciation in the value of our investments in SLR Equipment Finance, SLR-AMI Topco Blocker,
Current report — wording carried from elsewhere
LLC, OmniGuide Holdings, Inc. and RQM+ Corp., among others, as well as the reversal of previously recognized unrealized
Current report — wording carried from elsewhere
appreciation upon the exit of our investments in Outset Medical, Inc. and Retina Midco, Inc.
Rearranged previous paragraphs (8)
Previous report — wording carried elsewhere
On May 5, 2026, the Board authorized an extension of a program for the purpose of repurchasing up to $50 million of the
Previous report — wording carried elsewhere
repurchase shares of the Company’s outstanding common stock in the open market from time to time provided that the Company
Previous report — wording carried elsewhere
complies with the Company’s code of ethics and the guidelines specified in Rule 10b-18 of the Securities Exchange Act of 1934, as
Previous report — wording carried elsewhere
amended (the “1934 Act”), including certain price, market volume and timing constraints. In addition, any repurchases will be
Previous report — wording carried elsewhere
conducted in accordance with the 1940 Act. Unless further amended or extended by the Board, the Company expects the repurchase
Previous report — wording carried elsewhere
program to be in place until the earlier of May 5, 2027 or until $50 million of the Company’s outstanding shares of common stock have been repurchased. The timing and number of additional shares to be repurchased will depend on a number of factors, including
Previous report — wording carried elsewhere
market conditions. There are no assurances that the Company will engage in any repurchases.
Previous report — wording carried elsewhere
On March 16, 2026, as per the terms of the original purchase agreement, the Company acquired an additional 6.25% of KBHT’s equity from the KBH management team. Effective with these purchases, the Company owns 100% of KBHT’s equity.